RARA CRAFT DATABASE for FDA Medical Devices
510(k)K231329

FDA DEVICE FACTS

Aptima Neisseria gonorrhoeae Assay

Hologic, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 26, 2024PRODUCT CODELSL

Indications for use

The Aptima Neisseria gonorrhoeae (GC) Assay is an in vitro qualitative nucleic acid amplification (NAAT) test for the detection of ribosomal RNA (rRNA) from Neisseria gonorrhoeae (GC) to aid in the diagnosis of gonococcal urogenital disease using the Panther System. The assay may be used to test urine from symptomatic and asymptomatic male individuals. Indications for Use Comparison This pre-market application is to clear the Aptima Neisseria gonorrhoeae Assay on an additional platform, the Panther system, for use with male urine specimen type indications. The analytical and clinical study results demonstrate that the Aptima Neisseria gonorrhoeae Assay on the Panther system performs comparably to the predicate device in detecting rRNA of GC from the designated specimen type and support a substantial equivalence decision.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 17, 2026